TFS HealthScience
↗Lund, Sweden
TFS HealthScience is a leading global mid-size Contract Research Organization (CRO) that supports biotechnology and pharmaceutical companies throughout the entire clinical development lifecycle. Founded in 1996 and headquartered in Sweden, the company provides a full suite of services including clinical operations, regulatory affairs, medical writing, and data management. TFS is known for its flexible 'Functional Service Provider' (FSP) model and its specialized focus on high-growth therapeutic areas.
The company operates in over 50 countries with a strong presence in Europe and North America, and recently expanded into the Asia-Pacific region with a new operational base in Australia. TFS differentiates itself by combining the global reach of a large CRO with the agility and personalized approach of a mid-sized firm, catering specifically to small and mid-sized biotech companies that require high-touch service and deep therapeutic expertise.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Revenue:$100M-$250M
Founded:1996
Ownership:subsidiary
Status:operating
FUNDING
Stage:Acquired
Total Raised:N/A (Wholly owned by Ratos AB)
Investors:Ratos AB
STOCK
Exchange:NASDAQ Stockholm (Parent: RATO B)
Ticker:RATO B
Market Cap:Parent Market Cap: ~$1.5B - $2B USD (approx. 15-20B SEK)
PIPELINE
Stage:Commercial
Lead Drug Stage:Service Provider (Phase I-IV)
Modalities:Small molecule, mAb, Cell therapy, Gene therapy, Medical Devices
Active Trials:500
Trial Phases:Phase 1: 100 | Phase 2: 200 | Phase 3: 150 | Phase 4: 50
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Ratos AB
Acquired By:Ratos AB (2015-09-01)
Subsidiaries:Appletree CI Group, Beardsworth Properties LLC, SCIderm GmbH
Key Partnerships:Duke Clinical Research Institute (DCRI) - Data management, Veeva Systems - Safety database solutions, Oncomatryx - Pancreatic cancer clinical trials, Paradigm Application Solutions - Technology integration
COMPETITION
Position:Niche Player
Competitors:Medpace, Novotech, Emmes, Syneos Health, ICON, IQVIA, Worldwide Clinical Trials
LEADERSHIP
Key Executives:
Markus Granlund - CEO
Miriam Martin - VP, Business Development
Katarina Ageborg - Chairman of the Board
Scientific Founders:Daniel Spasic
Board Members:Katarina Ageborg (Chair), Jonas Wiström (Ratos CEO)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with TFS HealthScience. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.